DNA-binding proteins that interact with the 3' end of the mouse ,u immunoglobulin heavy chain gene were identified by the electrophoretic mobility shift assay. Complexes of distinctly different mobilities were formed by extracts prepared from B lymphoid lines representing different stages of maturation. The apparent stage-specific differences are shown to be due to proteolytic events that occurred during extract preparation.
The electrophoretic mobility shift assay is a sensitive method used in many laboratories to identify factors which specifically bind to DNA sequences. Complexes formed when nuclear factors bind to a DNA fragment migrate with reduced mobility relative to the noncomplexed DNA fragment (4, 5) . This assay has been used extensively in studies of the regulatory regions of the immunoglobulin genes (1, 6, 9, 17, 18, (20) (21) (22) (23) (24) 26) . We have also been using the assay to examine immunoglobulin gene sequences located at the 3' end of the p. heavy chain gene for potential regulatory regions involved in transcription termination (11, 19) . Because studies of rRNA transcription have indicated that DNA-binding proteins play a role in termination of transcription of those genes (8) , it was of interest to determine whether proteins could be identified which bind specifically to sequences near the termination site(s) in the p.-8 gene. Four factor-binding sites have been identified; they will be described later in detail (manuscript submitted). Here I report an important observation made during these experiments which indicates that some of the DNA-protein complexes detected by the electrophoretic mobility shift assay result from alterations of DNA-binding factors which occur during extract preparation.
B lymphomas were used as representatives of B lymphocytes, and hybridomas and myelomas were used as representatives of activated B lymphocytes. Nuclei were prepared by homogenizing washed cells in a buffer consisting of 25 mM Tris hydrochloride, 25 mM KCI, 7.5 mM MgCl2, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 0.05% or 0.1% Nonidet P-40, and 30% sucrose, pH 7.5. The nuclei were pelleted by centrifugation at 1,700 x g for 15 min, and nuclear proteins were extracted with 0.4 M KCl-10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.9)-1.5 mM MgCI2-0.1 mM EDTA-0.5 mM dithiothreitol-0.5 mM PMSF-5% glycerol-0.3 M sucrose for 30 min at 4°C. The extracts were dialyzed for 5 h against 20 mM HEPES (pH 7.9)-75 mM KCl-0.1 mM EDTA-0.5 mM dithiothreitol-0.2 mM PMSF-20% glycerol. After centrifugation at 12,000 x g, the extracts were frozen in liquid nitrogen and stored at -80°C. For the binding assay, 3 Fig. 1E ) produced complexes that migrated with reduced mobility (Fig. 1A) . The pattern of complexes observed differed depending upon whether the extract was prepared from lymphoma cell lines or from hybridoma and myeloma cell lines. Two bands showing retarded mobility were observed when the DNA fragment was incubated with the lymphoma extracts (Fig. 1A, lanes 1 and 2) , whereas three additional, more rapidly migrating complexes were observed when the fragment was incubated with hybridoma or myeloma extracts (Fig. 1A, lanes 4 to 6) . These results suggested that activated B lymphocytes have different DNA-binding factors that interact with a DNA sequence located at the 3' end of the ,u gene. To determine whether the change in DNA-binding factors was induced by activation of B lymphocytes, I made use of the ability of the B lymphoma X16c8.5 to undergo activation events when treated with the mitogen lipopolysaccharide (LPS) (12) . Incubation of the DNA fragment with nuclear extract prepared from the mitogen-treated lymphoma produced complexes similar to those produced by the hybridoma and myeloma extracts ( (Fig. 1B, lanes 1 and 2) , and two additional, more rapidly migrating complexes were observed when the fragment was incubated with hybridoma, myeloma, or LPS-treated X16c8.5 extracts (Fig. 1B , lanes 3 to 6).
These results suggested that there was an activationdependent alteration in the DNA-binding factors that interact with DNA sequences located at the 3' end of the p. gene. However, additional experiments suggested an alternative interpretation of the data. First, analogous results were obtained with a variety of other DNA fragments that formed specific complexes. These fragments included two additional fragments isolated from the 3' end of the p. gene (data not shown), a fragment isolated from the enhancer region of the p. gene (fragment C, Fig. 1C , lanes 1 to 4), and a fragment isolated from the promoter region of the I-An gene of the d haplotype ( Fig. 1D , lanes 1 to 4). All of these DNA fragments showed similar types of DNA-protein complex formation when extracts from the two cell types were compared; that is, the lymphoma extracts produced a limited number of low-mobility bands, whereas the hybridoma and myeloma extracts produced multiple bands of greater mobility. More 4) and lymphoma WEHI 231 nuclear extract, which produces the same mobility shift pattern as do 38C-13 and X16c8.5 (lanes 5 to 6), were incubated with the 154-bp fragment, treated with dimethylsulfate, and electrophoresed on 4% polyacrylamide gels. Free and complexed DNA fragments were eluted from the gel, treated with piperidine, and analyzed on an 8% polyacrylamide sequencing gel. The doublet bands of complex 1 and of complex 2 (Fig. 1A) were combined for these analyses. Lanes: M, MspI-digested pBR322 marker fragments; 1 and 5, noncomplexed DNA fragment; 2, complex 3; 3, complex 2; 4 and 6, complex 1. Numbers at the left indicate the lengths (in nucleotides) of the marker fragments. Arrows indicate the positions of bands which were underrepresented in the complexed DNA. No other underrepresented bands were observed. (B) Coding strand analysis. Preparative binding reactions were carried out with D2 extract and the 203-bp fragment. Free DNA and complexed DNA were prepared as described in panel A and analyzed on a 6% sequencing gel. Lanes: M, MspI-digested pBR322 marker fragments; 7, free DNA; 8, complex 3; 9, complex 2; 10, complex 1. (C) Sequence surrounding residues protected from methylation. The G residues protected from methylation by complex formation are highlighted with asterisks.
The ALm polyadenylylation signal is underlined.
Moreover, binding studies conducted with mixed extracts also indicated that little protease activity remained after the extract had been stored (data not shown).
These results indicate that limited proteolytic cleavage of DNA-binding proteins can occur during extract preparation and suggest that some of the DNA-binding factors of B lymphoid cells that have been thought to be cell type or stage specific may, in fact, result from differences in the proteases present in the cells being compared (1, (16) (17) (18) . Our results indicate that the amount of protease activity is more abundant in hybridomas and myelomas than in lymphomas, a result concordant with previous studies showing that B lymphoid cells have increased levels of protease activity after mitogen-induced activation (13) (14) (15) . Although the hypotonic method of cell lysis, the most commonly used procedure, decreased the amount of the more rapidly migrating complexes, the hybridoma extracts prepared by this procedure still showed a low, but easily discernible, level of these complexes (Fig. 1B, lane 6) . Presumably, minor variations in experimental procedures could alter the relative amount of proteolytic cleavage that occurs during extraction such that the cleaved binding proteins which form the smaller complexes become more or less abundant. Addition of the protease inhibitor leupeptin proved to be an effective way of preventing limited cleavage of the four DNA-binding proteins examined. Even with long autoradiography exposures, the major, more rapidly migrating complexes previously observed in extracts prepared from detergent-lysed hybridoma cells were not observed. A few other minor bands were seen with extracts prepared in the presence of leupeptin. These bands may arise from the action of other proteases not inhibited by PMSF or leupeptin which may be present in low amounts in these cell types. While it is possible that some of the DNA-binding factors which produce the niore rapidly migrating complexes preexist in these cells and play a role, the results presented here suggest that caution should be exercised in interpreting stage-specific DNA-binding factors in B lymphoid cells. These results also raise the possibility that some of the multiple bands commonly seen in electrophoretic shift assays using extracts from other cell types might arise during extract preparation.
These results also provide potentially important information about the structure of these DNA-binding proteins. That is, these proteins appear to have a domain structure, and the DNA-binding domain maintains its binding properties in the absence of other domains. This is reminiscent of the properties of several well-characterized regulatory molecules, including the prokaryotic LexA protein, the yeast Gln4 protein, and steroid-type receptor molecules (2, 7, 10). This work was supported by Public Health Service grants AI20443 and GM39228 from the National Institutes of Health.
